Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

BACKGROUND: In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhipeng, Zhang, Nengwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320462/
https://www.ncbi.nlm.nih.gov/pubmed/25543664
http://dx.doi.org/10.1186/1477-7819-12-397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320462/
https://www.ncbi.nlm.nih.gov/pubmed/25543664
http://dx.doi.org/10.1186/1477-7819-12-397

Ejemplares similares